Michael Ellenbogen sells $454,594 of Evolv Technologies stock
Michael Ellenbogen, a director at Evolv Technologies Holdings Inc. (NASDAQ:EVLV), sold 80,745 shares of the company's Class A Common Stock for $454,594 on May 15, 2026. This transaction was conducted under a Rule 10b5-1 trading plan after he exercised stock options. Following the sale, Ellenbogen directly holds over 2 million shares and indirectly holds 151,135 shares, with additional stock options.
Michael Ellenbogen sells $454,594 of Evolv Technologies stock
Michael Ellenbogen, a director at Evolv Technologies Holdings Inc. (NASDAQ:EVLV), sold 80,745 shares for $454,594, following his exercise of stock options. This sale was pre-planned, and Ellenbogen still holds a significant amount of shares and options. Despite the stock's recent decline, Evolv Technologies reported strong Q1 2026 earnings, exceeding revenue forecasts, leading TD Cowen to reiterate a Buy rating.
Evolv Technologies Holdings, Inc. (EVLV) Reports Q1 Loss, Beats Revenue Estimates
Evolv Technologies Holdings, Inc. (EVLV) reported a Q1 loss of $0.03 per share, beating the Zacks Consensus Estimate of a $0.06 loss and surprising by 50%. The company also surpassed revenue estimates, posting $46.33 million against an expectation of $32.01 million. Despite these positive surprises, EVLV shares have lost 3.4% year-to-date, contrasting with the S&P 500's 8.3% gain.
Evolv (NASDAQ: EVLV) CFO logs RSU vesting and tax-related share sale
Evolv Technologies Holdings, Inc.'s CFO, George C. Kutsor, engaged in a routine equity compensation activity, acquiring 138,888 shares through RSU exercise and subsequently selling 51,448 shares at $7.27 each. This sale was explicitly for covering tax withholdings related to the RSU vesting, not a discretionary transaction. Post-transaction, Kutsor holds 87,440 Class A common shares and 277,778 RSUs, which will vest in equal annual tranches over three years.
Evolv Technology Adds Philadelphia Union to Customer Roster, Bringing Company’s North American Professional Soccer Market Share to Fifty Percent
Evolv Technology has partnered with the Philadelphia Union, a Major League Soccer team, making it their fifteenth professional soccer team customer and bringing their North American professional soccer market share to 50%. The partnership will see Evolv Express® concealed weapons detection systems deployed at Subaru Park, ensuring enhanced security and efficient fan entry. This collaboration also establishes Evolv as the team's "Official Fan Screening Partner" with a media presence throughout the stadium campus.
[DEF 14A] Evolv Technologies Holdings, Inc. Definitive Proxy Statement
Evolv Technologies Holdings, Inc. (EVLV) has filed its definitive proxy statement (DEF 14A) for its 2026 annual meeting, detailing 40% revenue growth in 2025, an improved business model, and enhanced governance practices. Stockholders are asked to vote on electing two Class II directors, an advisory say-on-pay resolution, and ratifying PricewaterhouseCoopers LLP as the independent auditor. The company highlights its strong financial performance, disciplined execution, and a commitment to aligning executive compensation with performance and stockholder interests.
Philadelphia Union Announce Multi-Year Partnership with Evolv
The Philadelphia Union announced a multi-year partnership with Evolv Technologies Holdings, Inc., designating Evolv as the club's official Fan Screening Partner. Evolv Express uses AI-based sensor technology to detect concealed threats at entry points, aiming to enhance security while maintaining quick and convenient entry for fans. The partnership includes Evolv Express hardware and software for Subaru Park and a media presence throughout the stadium campus.
EVLV SEC Filings - Evolv Technologies Hldngs Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Evolv Technologies Holdings Inc. (EVLV) SEC filings, including 10-K, 10-Q, and 8-K reports, as well as insider trading forms. It highlights the company's financial performance, governance, and capital structure. The site also offers AI-powered summaries of these documents and tracks insider transactions.
EVOLV TECHNOLOGIES HOLDINGS, INC. (NASDAQ: EVLV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against E By Investing.com
Bernstein Liebhard LLP has issued a deadline alert for investors in Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) to file a lead plaintiff motion in a securities class action lawsuit. Investors who purchased EVLV shares between June 28, 2021, and March 13, 2024, and incurred losses, are encouraged to contact the firm by May 24, 2024. The lawsuit alleges that Evolv overstated the efficacy of its products, specifically regarding the detection of weapons, and that the company is under a non-public SEC investigation.
Evolv Technology Adds Philadelphia Union to Customer Roster, Bringing Company’s North American Professional Soccer Market Share to Fifty Percent
Evolv Technology has partnered with the Philadelphia Union, deploying its Evolv Express® concealed weapons detection systems at Subaru Park. This multi-year agreement makes Evolv the team's "Official Fan Screening Partner" and increases its North American professional soccer market share to 50%. The partnership also ensures Evolv's presence at all major professional sports venues in Philadelphia, emphasizing a commitment to enhancing safety and fan experience.
Evolv's Co-Founder Dumped Over 80,000 Company Shares. Here's What That Means for Investors.
Evolv Technologies Holdings co-founder Michael Ellenbogen sold over 80,000 Class A shares for approximately $510,000, executed as an exercise and immediate sale of stock options under a pre-arranged Rule 10b5-1 plan. This transaction is considered a systematic liquidity event rather than a red flag for investors, especially since Evolv's stock has performed strongly, and Ellenbogen retains significant holdings. The article advises potential investors to wait for a dip due to the stock's volatility, despite the company's recent strong revenue and net income growth.
Evolv Technologies director Ellenbogen sells $510k in shares By Investing.com
Evolv Technologies director Michael Ellenbogen sold 80,745 shares of Class A Common Stock for over $510,000 but simultaneously exercised options to acquire the same number of shares for a much lower price. This transaction occurred amidst a significant return in the stock's price over the past year, though it is currently trading above its Fair Value. The company also recently reported a 32% increase in Q4 2025 revenue and expanded its security screening agreement with Crypto.com Arena.
Evolv Technologies director Ellenbogen sells $510k in shares By Investing.com
Evolv Technologies director Michael Ellenbogen sold 80,745 shares for over $510,000, after the stock saw a 95% return in the past year. Concurrently, he exercised options to acquire the same number of shares for approximately $19,000. These transactions occurred under a Rule 10b5-1 trading plan.
Evolv Technologies director Ellenbogen sells $510k in shares
Michael Ellenbogen, a director at Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), sold 80,745 shares worth $510,308 on April 15, 2026, after the stock saw a 95% return but is trading above its Fair Value. Concurrently, he exercised options to acquire the same number of shares for $19,378. The company also reported a 32% revenue increase in Q4 2025 and expanded its security screening agreement with Crypto.com Arena.
Director Ellenbogen trades Evolv (EVLV) stock under 10b5-1 plan
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold a total of 80,745 Class A Common shares as part of a pre-planned Rule 10b5-1 trading arrangement. The shares were sold at a weighted average price of $6.32 per share, after exercising options at $0.24 per share. Following these transactions, Ellenbogen directly owns 2,083,961 Class A Common shares and indirectly holds an additional 151,135 shares through a family trust.
Evolv Technologies director Ellenbogen sells $510k in shares
Michael Ellenbogen, a director at Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), sold 80,745 shares of Class A Common Stock for over $510,000 on April 15, 2026, after the stock saw a 95% return but is trading above its fair value. On the same day, he exercised options to acquire an equal number of shares at a much lower price. The company recently reported a 32% revenue increase in Q4 2025 and expanded its security screening agreement with Crypto.com Arena.
General Catalyst (EVLV) joint 13G/A filing lists ≤5% ownership and joint agreement
General Catalyst has jointly filed a Schedule 13G/A concerning its ownership in Evolv Technologies Holdings, Inc. (EVLV), indicating an ownership of 5 percent or less of Class A Common Stock. The filing details the organizational structure of the various General Catalyst entities involved and highlights a Joint Filing Agreement for coordinated disclosure under SEC Rule 13d-1(k). This update is a routine compliance filing rather than a signal of a controlling stake.
Evolv Technologies director Ellenbogen sells $510k in shares By Investing.com
Michael Ellenbogen, a director at Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), sold 80,745 shares of Class A Common Stock for over $510,000 on April 15, 2026, after the stock saw a 95% return in the past year. Concurrently, Ellenbogen exercised options to acquire an equal number of shares at a much lower price. The company also recently reported a 32% increase in Q4 2025 revenue and expanded its security screening agreement with Crypto.com Arena.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Short Interest Down 24.4% in March
Evolv Technologies (NASDAQ:EVLV) experienced a 24.4% decrease in short interest in March, totaling 9,205,295 shares by month-end. Despite continued unprofitability, the company exceeded Q-1 earnings and revenue expectations. Insider selling has occurred, but analysts maintain a "Moderate Buy" consensus with an average price target of $9.13.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Given Consensus Recommendation of "Moderate Buy" by Analysts
Evolv Technologies Holdings, Inc. (EVLV) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $9.13. Despite beating quarterly earnings and revenue expectations, the company remains unprofitable. Insider selling has been noted, while institutional investors and hedge funds hold a significant portion of its stock.
Evolv Technology to Release First Quarter Financial Results on May 12, 2026
Evolv Technologies Holdings, Inc. will release its first quarter 2026 financial results on Tuesday, May 12, 2026, after the market closes. The company's management team will host a live webcast at 4:30 p.m. Eastern Time on the same day to discuss the results and business outlook. Evolv Technology specializes in AI-based security solutions for threat detection and risk mitigation in various venues.
Evolv Technologies Holdings, Inc. (EVLVW) Stock Price, News, Quote & History
This article provides a detailed overview of Evolv Technologies Holdings, Inc. (EVLVW), including its current stock price ($0.1460, up 5.04%), key financial metrics, recent performance against the S&P 500, and company information. Evolv Technologies specializes in security screening products like Evolv Express and Evolv eXpedite, serving various sectors. The report also lists top gainers, losers, and most active stocks.
SG Americas Securities LLC Boosts Stock Holdings in Evolv Technologies Holdings, Inc. $EVLV
SG Americas Securities LLC significantly increased its stake in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) by 637.1% in Q4, acquiring 599,215 additional shares to hold a total of 693,269 shares valued at approximately $4.96 million. This increase in institutional ownership comes amidst mixed analyst ratings, with a "Moderate Buy" consensus and an average target price of $9.13, despite a recent "sell" rating from Weiss Ratings. The company reported strong Q4 earnings, beating estimates with $0.06 EPS and $38.5 million in revenue, though insider selling activity was also noted.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Short Interest Update
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) saw a significant increase in short interest by 29.5% in March, reaching 12,169,723 shares, representing 7.6% of its stock with a short-interest ratio of 2.7 days. Insider selling activity was noted, with Director Michael Ellenbogen selling shares, though insiders still own 11.30% of the company. Meanwhile, institutional investors like Stoic Point, Millennium Management, and Vanguard Group Inc. increased their stakes, bringing institutional ownership to 66.65%.
Vanguard amends Schedule 13G/A, reports 0 shares in Evolv (NASDAQ: EVLV)
Vanguard has filed an amended Schedule 13G/A for Evolv Technologies Holdings Inc. (NASDAQ: EVLV), reporting 0 shares beneficially owned and 0% ownership as of March 13, 2026. This amendment follows an internal realignment on January 12, 2026, which enables certain Vanguard subsidiaries to report their beneficial ownership separately in reliance on an SEC release. The filing clarifies that The Vanguard Group no longer claims beneficial ownership for securities held by these reallocated subsidiaries.
Houston Astros Enter Multi-Year Renewal and Expansion of Partnership with Evolv Technology
Evolv Technologies Holdings, Inc. announced a multi-year renewal and expansion of its partnership with the Houston Astros. This agreement upgrades existing Evolv Express® units to Gen2 hardware and introduces Evolv eXpedite™ bag screening systems at Daikin Park, making the Astros the first professional baseball team to deploy this technology. The updated security solutions aim to enhance guest and staff experience by efficiently detecting threats and minimizing entry point congestion.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Given Average Rating of "Moderate Buy" by Brokerages
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) has received a "Moderate Buy" consensus rating from six brokerages that cover the company, with an average 12-month target price of $9.13. Despite some insider selling and the company currently being unprofitable, Evolv recently reported better-than-expected EPS and revenue. Institutional investors hold a significant stake in the company, and its AI-driven security technology is positioned in a growing market.
Evolv Technologies (NASDAQ: EVLV) outlines AI security growth, losses and control risks
Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) describes itself as an AI-powered security technology company providing Security-as-a-Service weapons screening solutions for high-traffic venues. The company reported continued losses, with net losses of $33.1 million in 2025 and $54.0 million in 2024, and an accumulated deficit of $387.8 million. Evolv highlights a large addressable market, recurring revenue metrics like ARR ($120.5 million in 2025), and strategies for growth despite disclosing material weaknesses in internal control over financial reporting that led to prior restatements.
Evolv (EVLV) director Ellenbogen sells 91,771 shares under Rule 10b5-1 plan
Evolv Technologies Holdings, Inc. director Michael Ellenbogen sold 91,771 shares of Class A common stock at a weighted average price of $5.10 per share under a pre-arranged Rule 10b5-1 trading plan established in June 2025. After this transaction, Ellenbogen directly holds over 2 million shares and indirectly holds an additional 151,135 shares through the Family Horizon Trust. The sale, which occurred at prices ranging from $5.04 to $5.17, represents a moderate impact and negative sentiment filing due to the insider selling.
Evolv Technology (NASDAQ: EVLV) lifts 2026 outlook after strong 2025
Evolv Technology (NASDAQ: EVLV) reported strong financial results for Q4 and full-year 2025, with revenues reaching $38.5 million in Q4 and $145.9 million for the year, representing a 40% increase from 2024. The company also turned profitable with a Q4 net income of $10.9 million and positive Adjusted EBITDA of $11.1 million for the full year. Due to this performance, Evolv has raised its 2026 outlook, projecting total revenue of $172-$178 million and ending Annual Recurring Revenue (ARR) of $145-$150 million, along with positive full-year Adjusted EBITDA margins in the high single digits.
Earnings Flash (EVLV) Evolv Technologies Holdings, Inc Posts Q4 Adjusted Loss $0.03 per Share, vs. FactSet Est of $-0.04
Evolv Technologies Holdings, Inc. (EVLV) announced a Q4 adjusted loss of $0.03 per share, which is better than the FactSet estimate of a $0.04 per share loss. This news was released by MT Newswires on March 10, 2026. The company specializes in AI-based weapons detection for various facilities, including athletic venues and public spaces.
[144] Evolv Technologies Holdings, Inc. SEC Filing
Evolv Technologies Holdings, Inc. (EVLV) filed a Form 144, notifying proposed sales of Class A Common stock. The filing details ongoing insider activity, including proposed sales from stock option exercises and restricted stock vesting in early March 2026, as well as past sales by Michael P. Ellenbogen from December 2025 to February 2026. The SEC Form 144 is a required notification of intent to sell restricted or controlled securities, with J.P. Morgan Securities LLC identified as the broker.
Evolv Technologies (EVLV) CRO granted 186,915 restricted stock units
Evolv Technologies Holdings, Inc. (EVLV) Chief Revenue Officer, Robert E. Marshall, was granted 186,915 Restricted Stock Units (RSUs) on March 2, 2026. These RSUs represent a contingent right to receive one share of Class A common stock each, with no expiration date. The award will vest in three equal annual installments, beginning on March 2, 2027, and was granted with a price of $0, indicating a compensatory equity award.
EVLV SEC Filings - Evolv Technologies Hldngs Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Evolv Technologies Holdings (EVLV) SEC filings, including 10-K, 10-Q, and 8-K reports, offering insights into the company's financial performance, governance, and key events. It highlights recent insider transactions, specifically the grant of Restricted Stock Units (RSUs) to board members in June 2025, which are standard equity compensation. The platform also offers AI-powered summaries to help investors understand lengthy documents.
[Form 4] Evolv Technologies Holdings, Inc. Insider Trading Activity
John Kedzierski, President & CEO of Evolv Technologies Holdings, Inc., reported acquiring 373,831 Restricted Stock Units (RSUs) in a recent Form 4 filing. These RSUs, which represent Class A common stock and were granted at no cash cost, vest in three equal annual installments starting March 2, 2027. This equity-based compensation aims to align the CEO's interests with long-term shareholder performance and retention.
EVLV SEC Filings - Evolv Technologies Hldngs Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Evolv Technologies Holdings (EVLV) SEC filings, including annual 10-K reports, quarterly 10-Q reports, and 8-K material event forms. It details how the company reports financial performance, governance, and key agreements related to its AI-powered security screening business. The site also offers AI-powered summaries of these filings and tracks insider transactions, offering insights into the company's financial condition and corporate events.
Evolv Technologies (EVLV) founder sells 63,670 shares to cover taxes
Evolv Technologies (EVLV) founder and Chief Growth Officer Anil Chitkara sold 63,670 Class A common shares at a weighted average price of $5.19 per share. This sale was primarily to cover withholding taxes related to the vesting of Restricted Stock Units (RSUs). Following these transactions, Chitkara directly owns 1,348,651 Class A common shares and retains additional unvested RSUs.
Vanguard Group Inc. Acquires 1,750,073 Shares of Evolv Technologies Holdings, Inc. $EVLV
Vanguard Group Inc. increased its stake in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) by 17.1% in the third quarter, acquiring an additional 1,750,073 shares to own a total of 11,981,998 shares, valued at approximately $90.46 million. This makes Vanguard Group Inc. the largest institutional holder with 6.97% of the company's stock. Other institutional investors also modified their holdings, while a director sold shares, bringing insider ownership to 11.30%.
Bank of America Stadium Readies for 2026 Charlotte FC Season with Renewal of Evolv Express
Evolv Technologies Holdings, Inc. announced the renewal and expansion of its security hardware and software subscription with Bank of America Stadium in Charlotte, North Carolina. The stadium will upgrade its Evolv Express® systems to the latest Gen2 hardware and add Evolv eXpedite™ bag screeners for the 2026 MLS season, enhancing security and improving the fan entry experience. This multi-year agreement highlights Evolv's continued partnership with major sports venues, aiming to create safer and more efficient entry points.
Evolv Technologies : EVLV
Evolv Technologies Holdings Inc. (EVLV) specializes in AI-based security screening solutions, including its flagship product Evolv Express for touchless threat detection and Evolv Insights for analytics. The article highlights that EVLV is based in Waltham, Massachusetts, and operates globally to enhance security efficiency. It also mentions a related article about small-cap stocks, including EVLV, that are performing well.
Evolv Technologies (EVLV) Projected to Post Earnings on Tuesday
Evolv Technologies (EVLV) is expected to post its Q4 2025 earnings after the market closes on Tuesday, March 10th, with analysts projecting a loss of ($0.08) per share and revenue of $36.444 million. Insider activity shows a director sold over 80,000 shares in February, though institutional investors have been buying, with 66.65% of the stock owned by institutions. The company currently holds a "Moderate Buy" rating from analysts with an average target price of $9.13.
Miami Freedom Park Selects Evolv Technology for All Guest Ingress Screening at New World-Class Stadium
Evolv Technologies Holdings, Inc. announced that its Evolv Express® and Evolv eXpedite™ systems have been selected for security screening at Inter Miami CF's new stadium at Miami Freedom Park, opening in April 2026. This partnership designates Evolv as the "Official Fan Screening Provider of Miami Freedom Park," expanding Evolv's presence in professional sports venues to over 60 teams and locations in the U.S. and Canada. The deployment aims to provide efficient and welcoming security experiences for fans at the new 25,000-seat stadium.
Evolv Technologies Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations
Evolv Technologies Holdings, Inc. has seen a recent stock price decline, reflecting mixed technical indicators, though it has outperformed the S&P 500 in longer-term returns over the past year and three years. The stock is currently priced at $4.90, down from $5.43, and technical analysis shows a bearish trend on weekly indicators but a bullish trend monthly. The company's fluctuating market position highlights the need for close monitoring of its performance metrics.
Shell Energy Stadium Enhances Live Event Experience with Evolv’s Screening Technology
Shell Energy Stadium, home to the Houston Dynamo FC and Houston Dash, has partnered with Evolv Technologies Holdings, Inc. to implement Evolv Express® screening technology. This multi-year agreement aims to enhance the guest experience by providing more efficient and streamlined entry for all events at the stadium using AI-based concealed weapons detection systems. The investment is part of the stadium's ongoing commitment to improving fan comfort and safety, especially with an upcoming schedule of numerous sports and entertainment events.
Synovus Financial Corp Takes Position in Evolv Technologies Holdings, Inc. $EVLV
Synovus Financial Corp recently acquired a new stake of 275,304 shares in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), valued at approximately $2.08 million, representing 0.16% ownership. Meanwhile, Director Michael Ellenbogen sold 80,745 shares, reducing his stake by 3.73%. Analysts have given EVLV a "Moderate Buy" rating with a consensus target price of $9.13.
AI weapons scanners under fire ahead of Opening Day, NFL Draft
A class-action investor lawsuit has been filed against Evolv Technologies, the maker of AI-based weapons detectors, alleging the company falsified testing results and misled investors about the effectiveness of its systems. Despite the lawsuit and an FTC investigation, many users in Michigan, including the Detroit Police Department and the Michigan State Capitol Commission, stand by Evolv's systems, citing their effectiveness in detecting threats. The lawsuit alleges the systems are far less effective than claimed, particularly for certain types of knives and micro-compact pistols, while Evolv attributes the claims to a short-seller campaign.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Receives Average Rating of "Moderate Buy" from Analysts
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) has received an average "Moderate Buy" rating from analysts, with a 12-month consensus target price of approximately $9.13. Insider Michael Ellenbogen recently sold 80,745 shares, reducing his stake by 3.73%, while institutional investors hold 66.65% of the company. The company reported a market cap of $878.34 million and a negative P/E ratio of -13.59.
CenterBook Partners LP Lowers Stock Position in Evolv Technologies Holdings, Inc. $EVLV
CenterBook Partners LP significantly reduced its stake in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) by 86.4% in the third quarter, selling over 1.9 million shares. Despite this, other institutional investors have modified their holdings, with the stock currently having a "Moderate Buy" rating from analysts and an average target price of $9.13. An insider also recently sold a substantial number of shares, decreasing their ownership.
Evolv Technologies Appoints Henrik Kühl to Board
Evolv Technologies Holdings (EVLV) announced the appointment of Henrik Kühl, a strategy and corporate development executive from Axon, as an independent Class III director to its board. This appointment follows the resignation of long-time director Bilal Zuberi and signals Evolv's continued focus on governance, capital allocation, and strategic growth. Kühl is also designated as an audit committee financial expert, and the company aims to enhance shareholder value with this new addition.
Evolv Technology Announces the Appointment of Henrik Kühl as a New Independent Director
Evolv Technology (NASDAQ: EVLV) has appointed Henrik Kühl to its Board of Directors and Audit Committee, effective February 12, 2026. Kühl, Senior Vice President of Strategy & Corporate Development at Axon, brings over 25 years of experience in corporate development and strategy to the role. Concurrently, Bilal Zuberi resigned from the Board after 13 years of service to pursue other endeavors.
